Scentists present the state of the art on the most recently identified pathogenic mechanisms of this serious inflammatory bowel disease-related complication, focusing on possible targets of antifibrotic therapies, management strategies, and factors that might predict fibrosis progression or response to treatment.
[Nature Reviews Gastroenterology & Hepatology]